Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics

Thakur, Sujata, Dhapola, Rishika, Sarma, Phulen, Medhi, Bikash, Reddy, Dibbanti HariKrishna · 2023 · Inflammation

Abstract

Alzheimer's disease, a neurodegenerative disease with amyloid beta accumulation as a major hallmark, has become a dire global health concern as there is a lack of clear understanding of the causative agent. It is a major cause of dementia which is increasing exponentially with age. Alzheimer's disease is marked by tau hyperphosphorylation and amyloid beta accumulation that robs people of their memories. Amyloid beta deposition initiated a spectrum of microglia-activated neuroinflammation, and microglia and astrocyte activation elicited expressions of various inflammatory and anti-inflammatory cytokines. Neuroinflammation is one of the cardinal features of Alzheimer's disease. Pro-inflammatory cytokine signaling plays multifarious roles in neurodegeneration and neuroprotection. Induction of proinflammatory signaling leads to discharge of immune mediators which affect functions of neurons and cause cell death. Sluggish anti-inflammatory system also contributes to neuroinflammation. Numerous pathways like NFκB, p38 MAPK, Akt/mTOR, caspase, nitric oxide, and COX are involved in triggering brain immune cells like astrocytes and microglia to secrete inflammatory cytokines such as tumor necrosis factor, interleukins, and chemokines and participate in Alzheimer's disease pathology. PPAR-γ agonists tend to boost the phagocytosis of amyloid beta and decrease the inflammatory cytokine IL-1β. Recent findings suggest the cross-link between gut microbiota and neuroinflammation contributing…

Overview

Integrity signals

Registry

Crossref · 10.1007/s10753-022-01721-1

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Research works printed but not linked: 10

  1. Sahab Uddin, Md, Abdullah Al Mamun, Md Tanvir Kabir, & Ghulam, Md Ashraf, May N Bin-Jumah, and Mohamed M Abdel-Daim. Multi-target drug candidates for multifactorial Alzheimer’s disease: AChE and NMDAR as molecular targets. https://doi.org/10.1007/s12035-020-02116-9/Published. · doi:10.1007/s12035-020-02116-9/published
  2. Shal, Bushra, Wei Ding, Hussain Ali, Yeong S. Kim, and Salman Khan. 2018. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease. Frontiers in Pharmacology 9. Frontiers Media S.A.: 548. https://doi.org/10.3389/FPHAR.2018.00548/BIBTEX. · doi:10.3389/fphar.2018.00548/bibtex
  3. Figueiredo-Pereira, Maria E., Patricia Rockwell, Thomas Schmidt-Glenewinkel, and Peter Serrano. 2015. Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Frontiers in Molecular Neuroscience 7. Frontiers Media S.A.: 1–20. https://doi.org/10.3389/FNMOL.2014.00104/BIBTEX. · doi:10.3389/fnmol.2014.00104/bibtex
  4. Liu et al. - 2017 - NF-κB signaling in inflammation - Signal Transduction and Targeted Therapy.pdf. · DOI · Paper page
  5. Mueed, Zeba, Pallavi Tandon, Sanjeev Kumar Maurya, Ravi Deval, Mohammad A. Kamal, and Nitesh Kumar Poddar. 2019. Tau and mTOR: the hotspots for multifarious diseases in Alzheimer’s development. Frontiers in Neuroscience 13. Frontiers Media S.A.: 1017. https://doi.org/10.3389/FNINS.2018.01017/BIBTEX. · doi:10.3389/fnins.2018.01017/bibtex
  6. Uddin, Md Sahab, Md Ataur Rahman, Md Tanvir Kabir, Tapan Behl, Bijo Mathew, Asma Perveen, George E. Barreto, May N. Bin-Jumah, Mohamed M. Abdel-Daim, and Ghulam Md Ashraf. 2020. Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer’s disease. IUBMB Life 72. John Wiley & Sons, Ltd: 1843–1855. https://doi.org/10.1002/IUB.2324. · DOI
  7. Lin, Li, Li Juan Zheng, and Long Jiang Zhang. 2018. Neuroinflammation, gut microbiome, and Alzheimer’s disease. Molecular Neurobiology 55. Humana Press Inc.: 8243–8250. https://doi.org/10.1007/S12035-018-0983-2/FIGURES/2. · doi:10.1007/s12035-018-0983-2/figures/2
  8. Zhao, Yang, Jianshuai He, Ning Yu, Changxin Jia, and Shilei Wang. 2020. Mechanisms of dexmedetomidine in neuropathic pain. Frontiers in Neuroscience 14. Frontiers Media S.A.: 330. https://doi.org/10.3389/FNINS.2020.00330/BIBTEX. · doi:10.3389/fnins.2020.00330/bibtex
  9. Prins, Niels D., John E. Harrison, Hui May Chu, Kelly Blackburn, John J. Alam, Philip Scheltens, Arnold, et al. 2021. A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease. Alzheimer’s Research and Therapy 13. BioMed Central Ltd: 1–12. https://doi.org/10.1186/S13195-021-00843-2/TABLES/3. · doi:10.1186/s13195-021-00843-2/tables/3
  10. Guo, Libing, Jiaxin Xu, Yunhua Du, Weibo Wu, Wenjing Nie, Dongliang Zhang, Yuling Luo, et al. 2021. Effects of gut microbiota and probiotics on Alzheimer’s disease. Translational Neuroscience 12. De Gruyter Open Ltd: 573–580. https://doi.org/10.1515/TNSCI-2020-0203/ASSET/GRAPHIC/J_TNSCI-2021-0203_FIG_001.JPG. · doi:10.1515/tnsci-2020-0203/asset/graphic/j_tnsci-2021-0203_fig_001.jpg

Cited by

See all 615

Metadata

Authors
Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H.
Affiliations
  • Central University of Punjab (IN)
  • All India Institute of Medical Sciences, Mangalagiri (IN)
  • Post Graduate Institute of Medical Education and Research (IN)
Venue
Inflammation
Published
2022-08-20
Volume
46
Issue
1
Pages
1-17
ISSN
  • 0360-3997 (ISSN-L)
  • 1573-2576
OpenAlex
W4294094040
Cited by
557
References
55
Citations by year
2026: 151 · 2025: 209 · 2024: 146 · 2023: 46 · 2022: 5
FWCI
10.51
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Inflammation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, neuroinflammation, amyloid-beta, tau hyperphosphorylation, microglial activation, astrocyte activation, inflammatory cytokines, anti-inflammatory cytokines, NF-κB signaling, p38 MAPK, Akt/mTOR signaling, caspases, nitric oxide, Cox, PPARγ agonists, gut microbiota, neuroprotection, neurodegeneration, anti-inflammatory agents
MeSH terms
Neuroinflammatory Diseases, Alzheimer Disease, Anti-Inflammatory Agents, Humans, Cytokines, Amyloid beta-Peptides, Microglia, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics. https://app.cochat.ai/papers/10.1007/s10753-022-01721-1
The paper
Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H. (2023). Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics. Inflammation. https://doi.org/10.1007/s10753-022-01721-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.